Dr. ARUNDHATI PANDE

Abstract

ABStract-

Mucormycosis is an aggressive opportunistic fungal infection.

AIM

The study aims at providing demographic data of the patients, risk factors for the disease , presenting

signs and symptoms, intervention done and outcome of the treatment.

METHODS

This was a prospective, interventional study done in a tertiary hospital carried out from May 2021 to

July 2021

RESULTS

With 40 patients under study, 95% patient had history of COVID-19. T2DM

was present in 62.5% while T1DM in 2.5%. These patients mainly received Intravenous Amphotericin-B

(92.5%) with Syrup Posaconazole. Functional Endoscopic Sinus

Surgery(FESS) was done. In Ophthalmic conservative line of 37.5% received Transcutaneous

Retrobulbar Amphotericin B (TRAMB) . 10% patients underwent Exenteration. Inspite of all the interventions, 22.5% succumbed.

CONCLUSION

Corticosteroids followed by DM were the commonest pre-disposing factor for COVID-19 related

Mucormycosis. Early FESS and timely TRAMB reduced the spread of it.